Publication:
Community-Based Approach in Vaccine Trials: Insights and Challenges from COVID-19 Vaccine Trials in Nepal

creativeworkseries.issn3059-9458
dc.contributor.authorKarki, Khem B.
dc.contributor.authorPradhan, Dina
dc.contributor.authorShakya, Stela
dc.contributor.authorAcharya, Ajit
dc.date.accessioned2025-07-25T06:12:56Z
dc.date.available2025-07-25T06:12:56Z
dc.date.issued2024
dc.descriptionKhem B. Karki Associate Professor, Department of Community Medicine and Public Health Maharajgunj Medical Campus, Institute of Medicine, Tribhuvan University Maharajgunj, Kathmandu, Nepal Dina Pradhan Society for Local Integrated Development Nepal (SOLID Nepal), Lalitpur, Nepal https://orcid.org/0009-0008-2171-6725 Stela Shakya Society for Local Integrated Development Nepal (SOLID Nepal), Lalitpur, Nepal https://orcid.org/0009-0009-4039-8491 Ajit Acharya Society for Local Integrated Development Nepal (SOLID Nepal), Lalitpur, Nepal
dc.description.abstractAbstract Vaccine trials in Nepal are not a new phenomenon. However, following the COVID-19 pandemic, there were several vaccine trials for COVID-19 vaccines in Nepal. Unlike previous trials, COVID-19 vaccine studies required swift and large-scale enrollment from communities. These trials aimed to recruit healthy individuals to evaluate the safety and efficacy of the vaccines in preventing the targeted disease. In the clinical trials other than vaccine, researchers can enroll patients with specific medical conditions with their consent from the hospital. In contrast, vaccine trials require researchers to recruit healthy volunteers, who are primarily found in community settings. Recruiting healthy individuals from these communities is challenging because it involves navigating various layers of community stakeholders who must be supportive and grant permission for participation. Therefore, community-wide engagement is crucial for vaccine trials. Communities need to be fully informed and positively engaged, despite potential negative influences from media and misconceptions about the trials. Despite these challenges, effective community interventions and engagement resulted in the successful enrollment of up to 4,600 participants across three trial centers within just two months. Conducting the clinical trial in Nepal with a community-based approach has been both enriching and effective. This strategy facilitated smooth implementation and deepened connections with the local population. Engaging with community leaders, stakeholders, and members helped overcome challenges such as participant recruitment and adverse event management. The active involvement of community members in various trial stages fostered trust, cooperation, and empowerment. This experience underscored the importance of community engagement, cultural sensitivity, and collaboration in achieving successful and sustainable clinical research.
dc.identifierhttps://doi.org/10.70280/njph(2024)v1i1.13
dc.identifier.urihttps://hdl.handle.net/20.500.14572/664
dc.language.isoen_US
dc.publisherCentral Department of Public Health
dc.titleCommunity-Based Approach in Vaccine Trials: Insights and Challenges from COVID-19 Vaccine Trials in Nepal
dc.typeArticle
dspace.entity.typePublication
local.article.typeViewpoint
oaire.citation.endPage82
oaire.citation.startPage79
relation.isJournalIssueOfPublication995f5861-26c4-4a59-b975-19498e2bbbd6
relation.isJournalIssueOfPublication.latestForDiscovery995f5861-26c4-4a59-b975-19498e2bbbd6
relation.isJournalOfPublicatione22b8587-89a9-4773-9145-6767ee3cd9c4

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
79-82.pdf
Size:
107.72 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.86 KB
Format:
Item-specific license agreed to upon submission
Description:

Collections